ORMP
ORAMED PHARMACEUTICALS INC.
+0.09 (+1.95%)4.71USD88.7K成交股數196M市值1.1本益比(近四季)98.0股價營收比–營收年增(近四季)2026-11-12下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 2 · 942K · 2 |
| 其中 10b5-1 計畫賣出 | 0 筆 |
| 近 180 天 買進 · 賣出金額 | 0 · 942K |
| 近 180 天 淨額 | −942K |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-02 | 07-02 | Hexter Joshua | COO & CBO | M 選擇權執行 | 50.0K | 3.69 | 185K | 1.1M | SEC |
| 2026-07-01 | 07-02 | Hexter Joshua | COO & CBO | S 公開市場賣出 | 137K | 4.46 | 611K | 1.0M | SEC |
| 2026-07-01 | 07-02 | Gabay Avraham | Chief Financial Officer | S 公開市場賣出 | 73.4K | 4.51 | 331K | 672K | SEC |
| 2026-03-30 | 03-31 | KIDRON NADAV | President and CEO | F 繳稅扣股 | 44.8K | 3.31 | 148K | 3.4M | SEC |
| 2026-03-30 | 03-31 | Kidron Miriam | Chief Scientific Officer | F 繳稅扣股 | 435K | 3.31 | 1.4M | 1.1M | SEC |
| 2026-03-17 | 03-18 | Kidron Miriam | Chief Scientific Officer | A 獲配股票 | 120K | – | – | 1.6M | SEC |
| 2026-03-17 | 03-18 | Gabay Avraham | Chief Financial Officer | A 獲配股票 | 95.9K | – | – | 745K | SEC |
| 2026-03-17 | 03-18 | Hexter Joshua | COO & CBO | A 獲配股票 | 95.9K | – | – | 1.2M | SEC |
| 2026-03-17 | 03-18 | KIDRON NADAV | President and CEO | A 獲配股票 | 167K | – | – | 3.4M | SEC |
| 2026-03-12 | 03-16 | KIDRON NADAV | President and CEO | G 贈與 | 100K | – | – | 3.3M | SEC |
| 2026-01-22 | 01-29 | KIDRON NADAV | President and CEO | M 選擇權執行 | 109K | – | – | 3.4M | SEC |
| 2026-01-22 | 01-29 | Hexter Joshua | COO & CBO | M 選擇權執行 | 19.0K | – | – | 1.1M | SEC |
| 2026-01-22 | 01-29 | Gabay Avraham | Chief Financial Officer | M 選擇權執行 | 19.0K | – | – | 649K | SEC |
| 2026-01-22 | 01-29 | Kidron Miriam | Chief Scientific Officer | M 選擇權執行 | 19.0K | – | – | 1.4M | SEC |
| 2026-01-14 | 01-21 | Kidron Miriam | Chief Scientific Officer | G 贈與 | 86.2K | – | – | 1.3M | SEC |
| 2025-12-31 | 01-05 | Mayer Arie | Director | A 獲配股票 | 30.0K | – | – | 163K | SEC |
| 2025-12-31 | 01-05 | KIDRON NADAV | President and CEO | A 獲配股票 | 233K | – | – | 2.9M | SEC |
| 2025-12-31 | 01-05 | Reznick Yehuda | Director | A 獲配股票 | 30.0K | – | – | 98.9K | SEC |
| 2025-12-31 | 01-05 | Reznick Yehuda | Director | A 獲配股票 | 6.3K | – | – | 105K | SEC |
| 2025-12-31 | 01-05 | KIDRON NADAV | President and CEO | A 獲配股票 | 327K | – | – | 3.2M | SEC |
| 2025-12-31 | 01-05 | Kidron Miriam | Chief Scientific Officer | A 獲配股票 | 115K | – | – | 1.4M | SEC |
| 2025-12-31 | 01-05 | Kidron Miriam | Chief Scientific Officer | A 獲配股票 | 121K | – | – | 1.3M | SEC |
| 2025-12-31 | 01-05 | Hexter Joshua | COO & CBO | A 獲配股票 | 97.3K | – | – | 930K | SEC |
| 2025-12-31 | 01-05 | Mayer Arie | Director | A 獲配股票 | 4.9K | – | – | 168K | SEC |
| 2025-12-31 | 01-05 | Shapiro Benjamin | Director | A 獲配股票 | 3.5K | – | – | 123K | SEC |
| 2025-12-31 | 01-05 | Hexter Joshua | COO & CBO | A 獲配股票 | 115K | – | – | 1.0M | SEC |
| 2025-12-31 | 01-05 | Shapiro Benjamin | Director | A 獲配股票 | 30.0K | – | – | 120K | SEC |
| 2025-12-31 | 01-02 | Aghion Daniel | Director | A 獲配股票 | 6.3K | – | – | 113K | SEC |
| 2025-12-31 | 01-02 | Aghion Daniel | Director | A 獲配股票 | 30.0K | – | – | 107K | SEC |
| 2025-12-31 | 01-02 | Gabay Avraham | Chief Financial Officer | A 獲配股票 | 115K | – | – | 630K | SEC |
| 2025-12-31 | 01-02 | Gabay Avraham | Chief Financial Officer | A 獲配股票 | 81.2K | – | – | 515K | SEC |
| 2025-06-05 | 06-09 | Shapiro Benjamin | Director | A 獲配股票 | 30.0K | – | – | 85.1K | SEC |
| 2025-06-05 | 06-09 | Mayer Arie | Director | A 獲配股票 | 7.0K | – | – | 133K | SEC |
| 2025-06-05 | 06-09 | Mayer Arie | Director | A 獲配股票 | 30.0K | – | – | 126K | SEC |
| 2025-06-05 | 06-09 | Shapiro Benjamin | Director | A 獲配股票 | 4.7K | – | – | 89.7K | SEC |
| 2025-06-05 | 06-09 | Reznick Yehuda | Director | A 獲配股票 | 30.0K | – | – | 60.6K | SEC |
| 2025-06-05 | 06-09 | Reznick Yehuda | Director | A 獲配股票 | 8.4K | – | – | 68.9K | SEC |
| 2025-06-05 | 06-09 | Aghion Daniel | Director | A 獲配股票 | 8.4K | – | – | 77.2K | SEC |
| 2025-06-05 | 06-09 | Aghion Daniel | Director | A 獲配股票 | 30.0K | – | – | 68.8K | SEC |
| 2025-06-05 | 06-09 | Sank Leonard | Director | A 獲配股票 | 30.0K | – | – | 128K | SEC |
| 2025-06-05 | 06-09 | Sank Leonard | Director | A 獲配股票 | 6.5K | – | – | 135K | SEC |
| 2025-02-11 | 02-11 | Hexter Joshua | COO & CBO | A 獲配股票 | 33.3K | – | – | 833K | SEC |
| 2025-02-11 | 02-11 | Hexter Joshua | COO & CBO | A 獲配股票 | 48.5K | – | – | 800K | SEC |
| 2025-02-11 | 02-11 | Kidron Miriam | Chief Scientific Officer | A 獲配股票 | 66.7K | – | – | 1.2M | SEC |
| 2025-02-11 | 02-11 | Gabay Avraham | Chief Financial Officer | A 獲配股票 | 34.0K | – | – | 392K | SEC |
| 2025-02-11 | 02-11 | Kidron Miriam | Chief Scientific Officer | A 獲配股票 | 52.0K | – | – | 1.1M | SEC |
| 2025-02-11 | 02-11 | Kidron Miriam | Chief Scientific Officer | A 獲配股票 | 74.0K | – | – | 1.1M | SEC |
| 2025-02-11 | 02-11 | Hexter Joshua | COO & CBO | A 獲配股票 | 45.0K | – | – | 751K | SEC |
| 2025-02-11 | 02-11 | KIDRON NADAV | President and CEO | A 獲配股票 | 100K | – | – | 2.7M | SEC |
| 2025-02-11 | 02-11 | KIDRON NADAV | President and CEO | A 獲配股票 | 186K | – | – | 2.6M | SEC |
| 2025-02-11 | 02-11 | KIDRON NADAV | President and CEO | A 獲配股票 | 141K | – | – | 2.4M | SEC |
| 2025-02-11 | 02-11 | Gabay Avraham | Chief Financial Officer | A 獲配股票 | 42.0K | – | – | 434K | SEC |
| 2025-01-02 | 01-06 | Gabay Avraham | Chief Financial Officer | A 獲配股票 | 188K | – | – | 358K | SEC |
| 2025-01-02 | 01-06 | Hexter Joshua | COO & CBO | A 獲配股票 | 195K | – | – | 706K | SEC |
| 2025-01-02 | 01-06 | Kidron Miriam | Chief Scientific Officer | A 獲配股票 | 207K | – | – | 1.0M | SEC |
| 2025-01-02 | 01-06 | KIDRON NADAV | President and CEO | A 獲配股票 | 434K | – | – | 2.3M | SEC |
| 2024-11-07 | 11-08 | Kidron Miriam | Chief Scientific Officer | A 獲配股票 | 30.0K | – | – | 794K | SEC |
| 2024-11-07 | 11-08 | Gabay Avraham | Chief Financial Officer | A 獲配股票 | 30.0K | – | – | 170K | SEC |
| 2024-11-07 | 11-08 | Hexter Joshua | COO & CBO | A 獲配股票 | 30.0K | – | – | 512K | SEC |
| 2024-11-07 | 11-08 | KIDRON NADAV | President and CEO | A 獲配股票 | 45.0K | – | – | 1.8M | SEC |
| 2024-06-21 | 06-21 | Gabay Avraham | Chief Financial Officer | A 獲配股票 | 140K | – | – | 0 | SEC |
| 2024-06-06 | 06-10 | Reznick Yehuda | Director | A 獲配股票 | 760 | – | – | 30.6K | SEC |
| 2024-04-17 | 04-18 | Reznick Yehuda | Director | A 獲配股票 | 29.8K | – | – | 29.8K | SEC |
| 2024-01-30 | 01-30 | Aghion Daniel | Director | A 獲配股票 | 3.8K | – | – | 38.8K | SEC |
| 2024-01-04 | 01-08 | Shapiro Benjamin | Director | A 獲配股票 | 30.0K | – | – | 50.0K | SEC |
| 2024-01-04 | 01-08 | Hexter Joshua | COO & CBO | A 獲配股票 | 181K | – | – | 482K | SEC |
| 2024-01-04 | 01-08 | KIDRON NADAV | President and CEO | A 獲配股票 | 329K | – | – | 1.8M | SEC |
| 2024-01-04 | 01-08 | Rozov Yadin | Director | A 獲配股票 | 8.8K | – | – | 155K | SEC |
| 2024-01-04 | 01-08 | Sank Leonard | Director | A 獲配股票 | 9.3K | – | – | 98.0K | SEC |
| 2024-01-04 | 01-08 | Sank Leonard | Director | A 獲配股票 | 30.0K | – | – | 88.7K | SEC |
| 2024-01-04 | 01-08 | Aghion Daniel | Director | A 獲配股票 | 30.0K | – | – | 30.0K | SEC |
| 2024-01-04 | 01-08 | Rozov Yadin | Director | A 獲配股票 | 30.0K | – | – | 147K | SEC |
| 2024-01-04 | 01-08 | Mayer Arie | Director | A 獲配股票 | 9.3K | – | – | 96.1K | SEC |
| 2024-01-04 | 01-08 | Silberman David | Chief Financial Officer | A 獲配股票 | 137K | – | – | 367K | SEC |
| 2024-01-04 | 01-08 | Mayer Arie | Director | A 獲配股票 | 30.0K | – | – | 86.8K | SEC |
| 2024-01-04 | 01-08 | Aghion Daniel | Director | A 獲配股票 | 5.1K | – | – | 35.1K | SEC |
| 2024-01-04 | 01-08 | Shapiro Benjamin | Director | A 獲配股票 | 5.1K | – | – | 55.1K | SEC |
| 2024-01-04 | 01-08 | Kidron Miriam | Chief Scientific Officer | A 獲配股票 | 296K | – | – | 764K | SEC |
| 2023-05-26 | 05-31 | Hexter Joshua | COO & CBO | A 獲配股票 | 27.0K | – | – | 301K | SEC |
| 2023-05-26 | 05-31 | Silberman David | Chief Financial Officer | A 獲配股票 | 24.5K | – | – | 230K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| MERCER GLOBAL ADVISORS INC /ADV | 3.8M | 18.3M | +1.9M (+99%) | 加碼 |
| Aquamarine Financial (Cayman) Ltd | 2.5M | 12.1M | +400K (+19%) | 加碼 |
| Gem Investment Advisors, LLC | 2.0M | 9.6M | +359K (+22%) | 加碼 |
| BlackRock, Inc. | 1.6M | 7.7M | +1.5M (+1644%) | 加碼 |
| Murchinson Ltd. | 1.3M | 6.2M | −25.0K (-2%) | 減碼 |
| BML Capital Management, LLC | 866K | 4.2M | −2.3M (-73%) | 減碼 |
| BOOTHBAY FUND MANAGEMENT, LLC | 579K | 2.8M | −22.1K (-4%) | 減碼 |
| GEODE CAPITAL MANAGEMENT, LLC | 501K | 2.4M | +476K (+1962%) | 加碼 |
| GOLDMAN SACHS GROUP INC | 253K | 1.2M | 新進 | 新進 |
| STATE STREET CORP | 242K | 1.2M | 新進 | 新進 |
| Rathbones Group PLC | 233K | 1.1M | −233K (-50%) | 減碼 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 230K | 1.1M | 新進 | 新進 |
| DIMENSIONAL FUND ADVISORS LP | 203K | 974K | +44.4K (+28%) | 加碼 |
| NORTHERN TRUST CORP | 185K | 889K | 新進 | 新進 |
| 文藝復興 RENAISSANCE TECHNOLOGIES LLC | 184K | 884K | +36.1K (+24%) | 加碼 |
| WELLS FARGO & COMPANY/MN | 166K | 798K | +8.4K (+5%) | 加碼 |
| BANK OF AMERICA CORP /DE/ | 151K | 725K | +4.5K (+3%) | 加碼 |
| STRS OHIO | 134K | 644K | 新進 | 新進 |
| JANE STREET GROUP, LLC | 113K | 545K | +60.8K (+116%) | 加碼 |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | 103K | 495K | −13.4K (-12%) | 減碼 |
| MARSHALL WACE, LLP | 102K | 490K | −158K (-61%) | 減碼 |
| Hillsdale Investment Management Inc. | 89.3K | 430K | −8.0K (-8%) | 減碼 |
| RITHOLTZ WEALTH MANAGEMENT | 84.3K | 406K | −71.1K (-46%) | 減碼 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 83.6K | 402K | 新進 | 新進 |
| Bank of New York Mellon Corp | 79.3K | 381K | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 84 +20 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 29 / 9 / 21 / 20 |
| 機構合計持股 · 佔流通股 | 16.8M · 40.3% |
| 合計季末市值 | 80.0M |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 1.2M |
|---|---|
| 與上期比 | +12.5% |
| 佔流通股數 | 2.77% |
| 日均成交量 | 269K |
| 回補天數 | 4.3 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 1.2M | +12.5% | 2.77% | 269K | 4.3 |
| 2026-08-14 | 1.0M | +22.8% | 2.47% | 175K | 5.9 |
| 2026-07-31 | 835K | +9.2% | 2.01% | 147K | 5.7 |
| 2026-07-15 | 765K | -12.8% | 1.84% | 307K | 2.5 |
| 2026-06-30 | 878K | +53.9% | 2.11% | 739K | 1.2 |
| 2026-06-15 | 570K | -13.5% | 1.37% | 188K | 3.0 |
| 2026-05-29 | 659K | +3.8% | 1.59% | 214K | 3.1 |
| 2026-05-15 | 635K | -2.3% | 1.53% | 186K | 3.4 |
| 2026-04-30 | 651K | +12.8% | 1.56% | 146K | 4.5 |
| 2026-04-15 | 577K | +2.5% | 1.39% | 97.1K | 5.9 |
| 2026-03-31 | 563K | +4.0% | 1.35% | 103K | 5.5 |
| 2026-03-13 | 542K | -2.6% | 1.30% | 151K | 3.6 |
| 2026-02-27 | 556K | +3.0% | 1.34% | 154K | 3.6 |
| 2026-02-13 | 540K | -16.2% | 1.30% | 143K | 3.8 |
| 2026-01-30 | 645K | +57.8% | 1.55% | 247K | 2.6 |
| 2026-01-15 | 409K | -3.7% | 0.98% | 395K | 1.0 |
| 2025-12-31 | 424K | +34.6% | 1.02% | 126K | 3.4 |
| 2025-12-15 | 315K | -11.8% | 0.76% | 192K | 1.6 |
| 2025-11-28 | 357K | +45.8% | 0.86% | 380K | 1.0 |
| 2025-11-14 | 245K | +1.3% | 0.59% | 157K | 1.6 |
| 2025-10-31 | 242K | +15.9% | 0.58% | 116K | 2.1 |
| 2025-10-15 | 209K | -25.6% | 0.50% | 116K | 1.8 |
| 2025-09-30 | 280K | +25.1% | 0.67% | 123K | 2.3 |
| 2025-09-15 | 224K | -35.7% | 0.54% | 111K | 2.0 |
| 2025-08-29 | 348K | -4.5% | 0.84% | 83.8K | 4.2 |
| 2025-08-15 | 364K | -9.8% | 0.88% | 63.6K | 5.7 |